Excellent results for new prostate cancer test

I reported previously (July 2016) that Israel’s Micromedic Technologies had good results in an 18-patient trial of its CellDetect prostate cancer diagnosis solution. Latest tests on 59 samples were 80% successful – far exceeding the 25% for existing PSI tests.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *